Structured Abstract
Background Empirical evidence shows postpartum women are prescribed opioids at high rates following both cesarean and vaginal delivery. Beyond this, little is known about opioid prescribing to postpartum mothers following delivery hospitalization and the resulting impacts for maternal health. Postpartum women may be particularly vulnerable to adverse health effects from inappropriate prescribing.
Objectives This study examines the effects of postpartum opioid prescribing on emergency department (ED) utilization, controlling for delivery type and other maternal characteristics.
Study Design We conduct a retrospective cohort study using 2008-2016 data from the Medical Expenditure Panel Survey (MEPS).
Results We find 31% of women received a new opioid prescription following delivery, and that receipt of an opioid prescription following delivery hospitalization is associated with a 67% increase in the odds of an ED visit.
Conclusion This study is one of the first to test the relationship between opioid prescribing and healthcare utilization among this population, contributing critical information to our understanding of implications for opioid prescribing after childbirth for postpartum women.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Project is exempt.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The authors report no conflict of interest.
This work has been presented at the American Society of Health Economists (ASHEcon) Conference in Washington, DC on June 26th, 2019 and at the International Health Economics Association (iHEA) World Congress in Basel, Switzerland on July 15th, 2019.
Data Availability
All data are publicly available at the link provided.
